-transparent.png){kind=logo}
Three patients developed renal failure a few days after onset of sulfinpyrazone administration. In two the renal dysfunction was reversible, while the third died of a second myocardial infarction. The clinical picture of renal failure was uncharacteristic. It is recommended that renal function be tested two to four days after starting sulfinpyrazone, and to discontinue the drug immediately if there is a rise in blood urea nitrogen and creatinine. Since in two of the patients the creatinine values were elevated before sulfinpyrazone had been administered, it is clear that even minor pointers to impaired renal function should be considered as contraindications to the use of sulfinpyrazone.
E F Mayrhofer, and
G D Feilhauer, and
I Pilecky, and
H Vockner, and
P Kühn
January 1981,
Nephrologie,
E F Mayrhofer, and
G D Feilhauer, and
I Pilecky, and
H Vockner, and
P Kühn
July 1983,
Clinical nephrology,
E F Mayrhofer, and
G D Feilhauer, and
I Pilecky, and
H Vockner, and
P Kühn
October 1979,
Lijecnicki vjesnik,
E F Mayrhofer, and
G D Feilhauer, and
I Pilecky, and
H Vockner, and
P Kühn
April 1982,
South Dakota journal of medicine,
E F Mayrhofer, and
G D Feilhauer, and
I Pilecky, and
H Vockner, and
P Kühn
May 1998,
The American journal of the medical sciences,
E F Mayrhofer, and
G D Feilhauer, and
I Pilecky, and
H Vockner, and
P Kühn
January 1974,
Anales espanoles de pediatria,
E F Mayrhofer, and
G D Feilhauer, and
I Pilecky, and
H Vockner, and
P Kühn
November 1976,
Langenbecks Archiv fur Chirurgie,
E F Mayrhofer, and
G D Feilhauer, and
I Pilecky, and
H Vockner, and
P Kühn
October 1978,
Lijecnicki vjesnik,
E F Mayrhofer, and
G D Feilhauer, and
I Pilecky, and
H Vockner, and
P Kühn
September 1983,
Clinical nephrology,
E F Mayrhofer, and
G D Feilhauer, and
I Pilecky, and
H Vockner, and
P Kühn
August 1974,
Deutsche medizinische Wochenschrift (1946),
